The legal entity is THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD, commonly known as the University of Oxford, located in Oxford, UK. The Radcliffe Department of Medicine (RDM) is the clinical medicine department of the University of Oxford, and is where this research project will be coordinated. The RDM has multiple research groups and this project is coordinated through the Professor Antoniades laboratory, which is the Oxford Translational Cardiovascular Research Group. This group has extensive experience planning, coordinating and executing high quality retrospective and prospective research studies in cardiovascular science. The focus of the group is in computed tomography (CT) imaging of the heart, and in particular the coordination of two major cardiovascular risk studies that employ CT: The ORFAN Study and the AdipoRedOx Study.
The team:
Charalambos Antoniades MD PhD FRCP FESC
Professor of Cardiovascular Medicine
Director, Acute Vascular Imaging Centre
Deputy Head, Division of Cardiovascular Medicine University of Oxford
Consultant Cardiologist Oxford University Hospitals NHS Foundation Trust
Chair, British Atherosclerosis Society
Charis Antoniades is a full Professor of Cardiovascular Medicine and Consultant Cardiologist. He was awarded his PhD title with hons on the genetics of premature myocardial infarction, and during his PhD studies he won multiple Young Investigator award competitions, including those of the European Society of Cardiology (ESC) twice, the ISHR and others. He has been awarded the Outstanding Achievement Award of the basic Cardiovascular Science Council of the European Society of Cardiology in 2016, a National clinical excellence award in 2020 and has given various named lectures. He is the Director of Acute Vascular Imaging Centre of the University of Oxford, the Deputy Head of the Division of Cardiovascular Medicine and director of the Oxford Academic cardiovascular CT programme (and Oxford Academic Cardiovascular CT Core Lab). He is also the Chair of the British Atherosclerosis Society.
His research is focused on the study of the cross-talk between adipose tissue and the cardiovascular system, with specific interest in the non-invasive imaging of inflammation. He directs the Oxford Heart Vessels and Fat programme, and coordinates large national flagship programmes (such as the UK C19-CRC) and international multicentre studies (e.g. ORFAN study). His research has led to the development of novel imaging biomarkers using Computed Tomography, with major role in cardiovascular risk prognosis.
He is also deputy editor of Cardiovascular Research, one of the editors of British Journal of Pharmacology and associate editor of Hellenic Journal of Cardiology. He has published more than 300 peer review scientific papers in high impact journals such as The Lancet, Science Translational Medicine, Circulation, JACC, EHJ and others. He is one of the founders of the Scientists of Tomorrow of the ESC and vice chair in the Marie Curie Fellowships panel of the European Commission. He is also founder and Chief Scientific Officer of Caristo Diagnostics, a University of Oxford spinout company.
Henry West MD
PhD Candidate & Clinical Research Fellow, University of Oxford
Henry West is a Clinical Research Fellow in the Radcliffe Department of Medicine at the University of Oxford. He completed his medicine degree and initial clinical training at the University of Tasmania, Australia. Henry was awarded a Rhodes Scholarship (Tasmania & Balliol, 2018) to read his PhD at the University of Oxford. Henry works on the development of novel imaging-based tools for the early detection of atrial fibrillation and stroke risk.